Morepen Laboratories Limited

NSEI:MOREPENLAB Lagerbericht

Marktkapitalisierung: ₹42.7b

Morepen Laboratories Management

Management Kriterienprüfungen 3/4

Morepen Laboratories CEO ist Sushil Suri , ernannt in Oct 2000, hat eine Amtszeit von 24.08 Jahren. besitzt direkt 1.22% der Aktien des Unternehmens, im Wert von ₹522.17M . Die durchschnittliche Betriebszugehörigkeit des Managementteams und des Verwaltungsrats beträgt 7.9 Jahre bzw. 4.8 Jahre.

Wichtige Informationen

Sushil Suri

Geschäftsführender

₹39.1m

Gesamtvergütung

Prozentsatz des Geschäftsführergehaltsn/a
Amtszeit als Geschäftsführer24.1yrs
Eigentum des Geschäftsführers1.2%
Durchschnittliche Amtszeit des Managements7.9yrs
Durchschnittliche Amtszeit der Vorstandsmitglieder4.8yrs

Jüngste Management Updates

Increases to CEO Compensation Might Be Put On Hold For Now at Morepen Laboratories Limited (NSE:MOREPENLAB)

Sep 22
Increases to CEO Compensation Might Be Put On Hold For Now at Morepen Laboratories Limited (NSE:MOREPENLAB)

Recent updates

There's Reason For Concern Over Morepen Laboratories Limited's (NSE:MOREPENLAB) Massive 30% Price Jump

Aug 20
There's Reason For Concern Over Morepen Laboratories Limited's (NSE:MOREPENLAB) Massive 30% Price Jump

Impressive Earnings May Not Tell The Whole Story For Morepen Laboratories (NSE:MOREPENLAB)

Aug 09
Impressive Earnings May Not Tell The Whole Story For Morepen Laboratories (NSE:MOREPENLAB)

Improved Earnings Required Before Morepen Laboratories Limited (NSE:MOREPENLAB) Stock's 29% Jump Looks Justified

Jul 05
Improved Earnings Required Before Morepen Laboratories Limited (NSE:MOREPENLAB) Stock's 29% Jump Looks Justified

Does Morepen Laboratories (NSE:MOREPENLAB) Have A Healthy Balance Sheet?

Jun 13
Does Morepen Laboratories (NSE:MOREPENLAB) Have A Healthy Balance Sheet?

Morepen Laboratories Limited's (NSE:MOREPENLAB) Popularity With Investors Is Under Threat From Overpricing

Apr 23
Morepen Laboratories Limited's (NSE:MOREPENLAB) Popularity With Investors Is Under Threat From Overpricing

Morepen Laboratories (NSE:MOREPENLAB) Seems To Use Debt Quite Sensibly

Nov 23
Morepen Laboratories (NSE:MOREPENLAB) Seems To Use Debt Quite Sensibly

Increases to CEO Compensation Might Be Put On Hold For Now at Morepen Laboratories Limited (NSE:MOREPENLAB)

Sep 22
Increases to CEO Compensation Might Be Put On Hold For Now at Morepen Laboratories Limited (NSE:MOREPENLAB)

Is Morepen Laboratories (NSE:MOREPENLAB) Using Too Much Debt?

Aug 10
Is Morepen Laboratories (NSE:MOREPENLAB) Using Too Much Debt?

Increases to CEO Compensation Might Be Put On Hold For Now at Morepen Laboratories Limited (NSE:MOREPENLAB)

Sep 21
Increases to CEO Compensation Might Be Put On Hold For Now at Morepen Laboratories Limited (NSE:MOREPENLAB)

Should You Be Adding Morepen Laboratories (NSE:MOREPENLAB) To Your Watchlist Today?

Apr 05
Should You Be Adding Morepen Laboratories (NSE:MOREPENLAB) To Your Watchlist Today?

Do Morepen Laboratories's (NSE:MOREPENLAB) Earnings Warrant Your Attention?

Sep 14
Do Morepen Laboratories's (NSE:MOREPENLAB) Earnings Warrant Your Attention?

Is Morepen Laboratories (NSE:MOREPENLAB) Using Too Much Debt?

May 21
Is Morepen Laboratories (NSE:MOREPENLAB) Using Too Much Debt?

Does Morepen Laboratories (NSE:MOREPENLAB) Deserve A Spot On Your Watchlist?

Mar 12
Does Morepen Laboratories (NSE:MOREPENLAB) Deserve A Spot On Your Watchlist?

Our View On Morepen Laboratories' (NSE:MOREPENLAB) CEO Pay

Feb 22
Our View On Morepen Laboratories' (NSE:MOREPENLAB) CEO Pay

Is Morepen Laboratories Limited's (NSE:MOREPENLAB) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?

Feb 07
Is Morepen Laboratories Limited's (NSE:MOREPENLAB) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?

Morepen Laboratories (NSE:MOREPENLAB) Shareholders Have Enjoyed A 91% Share Price Gain

Jan 21
Morepen Laboratories (NSE:MOREPENLAB) Shareholders Have Enjoyed A 91% Share Price Gain

Morepen Laboratories (NSE:MOREPENLAB) Has A Pretty Healthy Balance Sheet

Jan 03
Morepen Laboratories (NSE:MOREPENLAB) Has A Pretty Healthy Balance Sheet

Is There More To The Story Than Morepen Laboratories's (NSE:MOREPENLAB) Earnings Growth?

Dec 16
Is There More To The Story Than Morepen Laboratories's (NSE:MOREPENLAB) Earnings Growth?

Should You Be Adding Morepen Laboratories (NSE:MOREPENLAB) To Your Watchlist Today?

Nov 28
Should You Be Adding Morepen Laboratories (NSE:MOREPENLAB) To Your Watchlist Today?

Analyse der Geschäftsführervergütung

Wie hat sich die Vergütung von Sushil Suri im Vergleich zu den Einnahmen von Morepen Laboratories verändert?
DatumGesamtvergütungGehaltUnternehmensgewinne
Sep 30 2024n/an/a

₹1b

Jun 30 2024n/an/a

₹1b

Mar 31 2024₹39mn/a

₹962m

Dec 31 2023n/an/a

₹761m

Sep 30 2023n/an/a

₹531m

Jun 30 2023n/an/a

₹477m

Mar 31 2023₹48m₹44m

₹387m

Dec 31 2022n/an/a

₹428m

Sep 30 2022n/an/a

₹553m

Jun 30 2022n/an/a

₹768m

Mar 31 2022₹91m₹87m

₹1b

Dec 31 2021n/an/a

₹1b

Sep 30 2021n/an/a

₹1b

Jun 30 2021n/an/a

₹1b

Mar 31 2021₹54m₹51m

₹971m

Dec 31 2020n/an/a

₹814m

Sep 30 2020n/an/a

₹684m

Jun 30 2020n/an/a

₹453m

Mar 31 2020₹17m₹16m

₹336m

Dec 31 2019n/an/a

₹331m

Sep 30 2019n/an/a

₹312m

Jun 30 2019n/an/a

₹340m

Mar 31 2019₹12m₹11m

₹288m

Dec 31 2018n/an/a

₹252m

Sep 30 2018n/an/a

₹267m

Jun 30 2018n/an/a

₹308m

Mar 31 2018₹6m₹4m

₹296m

Vergütung im Vergleich zum Markt: SushilDie Gesamtvergütung ($USD463.09K) liegt über dem Durchschnitt von Unternehmen ähnlicher Größe auf dem Markt Indian ($USD260.56K).

Entschädigung vs. Einkommen: SushilDie Vergütung des Vorstandsvorsitzenden entsprach im vergangenen Jahr der Unternehmensleistung.

Geschäftsführer

Sushil Suri (60 yo)

24.1yrs

Amtszeit

₹39,112,000

Vergütung

Mr. Sushil Suri, B.Sc., FCA has been Managing Director of Morepen Laboratories Limited since October 2000. He has been Chairman of Morepen Laboratories Limited since October 2000 and has been its Director...

Führungsteam

NamePositionAmtszeitVergütungEigentümerschaft
Sushil Suri
Chairman & MD24.1yrs₹39.11m1.22%
₹ 522.2m
Sanjay Suri
Whole-Time Director9.8yrs₹21.80m1.01%
₹ 429.8m
Ajay Sharma
Chief Financial Officer10.3yrs₹9.80mkeine Daten
Bhola Prasad
General Manager of Process Engineering & Technology Transferno datakeine Datenkeine Daten
Sunita Suri
Manager of Administrationno datakeine Daten0.58%
₹ 248.7m
Vipul Srivastava
Company Secretary & Compliance Officer6yrs₹1.84mkeine Daten
Vikas Sharma
Functional Head of Talent Acquisition & HRBPless than a yearkeine Datenkeine Daten
Amita Sharma
Chief Operating Officer of APIless than a yearkeine Datenkeine Daten
Anubhav Suri
Head of Medipath Divisionno datakeine Daten0.42%
₹ 177.8m
Kushal Suri
Head of International Business Developmentno datakeine Datenkeine Daten
Varun Suri
Chief Executive Officer of Consumer Divisionno datakeine Daten0.56%
₹ 237.8m
H. Manjunath
Chief of R&Dno datakeine Datenkeine Daten

7.9yrs

Durchschnittliche Betriebszugehörigkeit

47.5yo

Durchschnittliches Alter

Erfahrenes Management: MOREPENLABDas Führungsteam des Unternehmens verfügt über eine langjährige Erfahrung (7.9 ).

Vorstandsmitglieder

NamePositionAmtszeitVergütungEigentümerschaft
Sushil Suri
Chairman & MD32.8yrs₹39.11m1.22%
₹ 522.2m
Sanjay Suri
Whole-Time Director5.3yrs₹21.80m1.01%
₹ 429.8m
Sharad Jain
Independent Directorless than a yearkeine Datenkeine Daten
Praveen Dutt
Independent Director5.3yrs₹520.00kkeine Daten
- Savita
Independent Director4.4yrs₹300.00kkeine Daten
Ranjit Khattar
Independent Directorless than a yearkeine Datenkeine Daten

4.8yrs

Durchschnittliche Betriebszugehörigkeit

56yo

Durchschnittliches Alter

Erfahrener Vorstand: MOREPENLABDie Vorstandsmitglieder gelten als erfahren (4.8 Jahre durchschnittliche Amtszeit).